Overview
Aliquot reports the route limitation explicitly and withholds a route-mismatched half-life.
The source establishes human research context only. It is not used for a subcutaneous half-life statement or a personal-use conclusion.
Human pharmacokinetic context
Not published
Aliquot has not published a route-matched human half-life statement for this entry.
Half-life is descriptive population context, not a dosing interval, a prediction of an individual's response, or a recommendation. Route-mismatched and uncited estimates are withheld.
Limitations
- Intravenous evidence is not silently converted into subcutaneous evidence.
- A human study is not an approval record or recommendation.
Related calculation tools
Aliquot's browser-only tools transform values you already have. They do not select a compound, suggest an amount, provide presets, or store your entries.
Sources
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers Human intravenous research and route limitation.
- Drugs@FDA: FDA-approved drugs Regulatory database consulted; no approval conclusion is asserted.
- Aliquot compound library methodology Route-matching and withholding rules.